Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Clinical trial NCT04857359 · TERMINATED

Trial details

NCT number: NCT04857359
Sponsor: Addex Pharma S.A.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Disease Dyskinesia, Drug-Induced Dyskinesias

Start date: 2021-08-06
Primary completion: 2022-06-17
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.